Skip to main content
. 2021 May 18;64(4):353–363. doi: 10.5468/ogs.20316

Fig. 3.

Fig. 3

Systemic symptoms severity over the study period in the vitamin D and placebo groups. a)P <0.05; b)P <0.001.